Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Pain 1Neoplasms 1HIV Infections 1Chronic Pain 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × ziconotide × Clear all
NCT06541184 2025-02-27

Ziconotide for Non-cancer Pain by Intrathecal Administration

ESTEVE Pharmaceuticals SAS

Recruiting
85 enrolled

Chronic Pain

NCT00002160 2005-06-24

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
100 enrolled

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Neoplasms, Pain, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡